Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6331)
All Articles published online
|
Publishing Process of This Article
|
Sep 21, 2015 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kadiyska T, Nossikoff A. Stool DNA methylation assays in colorectal cancer screening. World J Gastroenterol 2015; 21(35): 10057-10061 [PMID: 26401070 DOI: 10.3748/wjg.v21.i35.10057] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i35/10057.htm |
| Number | Citing Articles |
| 1 |
Nathan H. Hite, David A. Margolin. Advances in colonoscopy and screening for colon cancer. Seminars in Colon and Rectal Surgery 2016; 27(4): 181 doi: 10.1053/j.scrs.2016.04.015
|
| 2 |
Angela Lopomo, Fabio Coppedè. Epigenetic Mechanisms in Cancer. 2018; : 313 doi: 10.1016/B978-0-12-809552-2.00012-7
|
| 3 |
Chang Woo Kim, Hyunjin Kim, Hyoung Rae Kim, Bong-Hyeon Kye, Hyung Jin Kim, Byung Soh Min, Tae Jeong Oh, Sungwhan An, Suk-Hwan Lee. Colorectal cancer screening using a stool DNA-based SDC2 methylation test: a multicenter, prospective trial. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01759-9
|
| 4 |
Tae Jeong Oh, Hyun Il Oh, Yang Yei Seo, Dongjun Jeong, Changjin Kim, Hyoun Woo Kang, Yoon Dae Han, Hyun Cheol Chung, Nam Kyu Kim, Sungwhan An. Feasibility of quantifying SDC2 methylation in stool DNA for early detection of colorectal cancer. Clinical Epigenetics 2017; 9(1) doi: 10.1186/s13148-017-0426-3
|
| 5 |
Yu-Xia Zhan, Guang-Hua Luo. DNA methylation detection methods used in colorectal cancer. World Journal of Clinical Cases 2019; 7(19): 2916-2929 doi: 10.12998/wjcc.v7.i19.2916
|
| 6 |
Bo-Jian Peng, Chuang-Yu Cao, Wei Li, Yong-Jian Zhou, Yuan Zhang, Yu-Qiang Nie, Yan-Wen Cao, Yu-Yuan Li. Diagnostic Performance of Intestinal Fusobacterium nucleatum in Colorectal Cancer. Chinese Medical Journal 2018; 131(11): 1349 doi: 10.4103/0366-6999.232814
|
| 7 |
Elisa H. F. Jandrey, Ricardo P. Moura, Luciana N. S. Andrade, Camila L. Machado, Luiz Felipe Campesato, Katia Ramos M. Leite, Lilian T. Inoue, Paula F. Asprino, Ana Paula M. da Silva, Alfredo Carlos S. D. de Barros, Andre Carvalho, Vladmir C. de Lima, Dirce M. Carraro, Helena P. Brentani, Isabela W. da Cunha, Fernando A. Soares, Raphael B. Parmigiani, Roger Chammas, Anamaria A. Camargo, Érico T. Costa. NDRG4 promoter hypermethylation is a mechanistic biomarker associated with metastatic progression in breast cancer patients. npj Breast Cancer 2019; 5(1) doi: 10.1038/s41523-019-0106-x
|
| 8 |
Nathalie Vaes, Simone L. Schonkeren, Erwin Brosens, Alexander Koch, Conor J. McCann, Nikhil Thapar, Robert M.W. Hofstra, Manon van Engeland, Veerle Melotte. A combined literature and in silico analysis enlightens the role of the NDRG family in the gut. Biochimica et Biophysica Acta (BBA) - General Subjects 2018; 1862(10): 2140 doi: 10.1016/j.bbagen.2018.07.004
|
| 9 |
Yan Tan, Juan-Juan Lin, XiaoFei Yang, De-Ming Gou, LiWu Fu, Fu-Rong Li, Xiao-Fang Yu. A panel of three plasma microRNAs for colorectal cancer diagnosis. Cancer Epidemiology 2019; 60: 67 doi: 10.1016/j.canep.2019.01.015
|
| 10 |
Xiuru Ying, Ranran Pan, Jie Zhong, Boyi Wu, Yuting Jiang, Jieer Ying, Cong Zhou, Jie Dai, Shuangying Zhao, Yinan Shen, Wei Zhang, Shiwei Duan. Significant association of EED promoter hypomethylation with colorectal cancer. Oncology Letters 2019; doi: 10.3892/ol.2019.10432
|
| 11 |
Ruikai Li, Chenxiang He, Liangliang Shen, Shuai Wang, Yao Shen, Fan Feng, Jian Zhang, Jianyong Zheng. NDRG4 sensitizes CRC cells to 5‑FU by upregulating DDIT3 expression. Oncology Letters 2021; 22(5) doi: 10.3892/ol.2021.13043
|
| 12 |
Dušan Braný, Dana Dvorská, Marián Grendár, Marcela Ňachajová, Peter Szépe, Zora Lasabová, Pavol Žúbor, Jozef Višňovský, Erika Halášová. Different methylation levels in the KLF4, ATF3 and DLEC1 genes in the myometrium and in corpus uteri mesenchymal tumours as assessed by MS-HRM. Pathology - Research and Practice 2019; 215(8): 152465 doi: 10.1016/j.prp.2019.152465
|
| 13 |
Yoon Dae Han, Tae Jeong Oh, Tae-Ha Chung, Hui Won Jang, Youn Nam Kim, Sungwhan An, Nam Kyu Kim. Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA. Clinical Epigenetics 2019; 11(1) doi: 10.1186/s13148-019-0642-0
|
| 14 |
Subroto Chatterjee, Rebecca Yuan, Spriha Thapa, Resham Talwar. Central Role of β-1,4-GalT-V in Cancer Signaling, Inflammation, and Other Disease-Centric Pathways. International Journal of Molecular Sciences 2023; 25(1): 483 doi: 10.3390/ijms25010483
|
| 15 |
Xiaoyu Fan, Chunli Shi, Meng Wei, Yanqun Xiao, Xueliang Wang. External quality assessment for detection of methylated Syndecan 2 (SDC2) in China. Clinical Chemistry and Laboratory Medicine (CCLM) 2022; 60(10): 1570 doi: 10.1515/cclm-2022-0206
|
| 16 |
Laura S. Chiu, Audrey H. Calderwood. Noninvasive Colorectal Cancer Prevention Options in Older Adults. Journal of Clinical Gastroenterology 2023; 57(9): 855 doi: 10.1097/MCG.0000000000001893
|
| 17 |
Wei-Chih Su, Wei-Yu Kao, Tsung-Kun Chang, Hsiang-Lin Tsai, Ching-Wen Huang, Yen-Cheng Chen, Ching-Chun Li, Yi-Chien Hsieh, Hsing-Jung Yeh, Chun-Chao Chang, Jaw-Yuan Wang. Stool DNA test targeting methylated syndecan-2 (SDC2) as a noninvasive screening method for colorectal cancer. Bioscience Reports 2021; 41(1) doi: 10.1042/BSR20201930
|
| 18 |
Barbara Kinga Barták, Alexandra Kalmár, Bálint Péterfia, Árpád V. Patai, Orsolya Galamb, Gábor Valcz, Sándor Spisák, Barnabás Wichmann, Zsófia Brigitta Nagy, Kinga Tóth, Zsolt Tulassay, Péter Igaz, Béla Molnár. Colorectal adenoma and cancer detection based on altered methylation pattern of SFRP1, SFRP2, SDC2, and PRIMA1 in plasma samples. Epigenetics 2017; 12(9): 751 doi: 10.1080/15592294.2017.1356957
|
| 19 |
Weisong Zhang, Chaogang Yang, Shuyi Wang, Zhenxian Xiang, Rongzhang Dou, Zaihuan Lin, Jinsen Zheng, Bin Xiong. SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal Cancer. Cancer Management and Research 2021; : 3601 doi: 10.2147/CMAR.S300861
|
| 20 |
Ji Hyeong Song, Tae Jeong Oh, Sungwhan An, Kyung Ha Lee, Ji Yeon Kim, Jin Soo Kim. Comparative detection of syndecan-2 methylation in preoperative and postoperative stool DNA in patients with colorectal cancer. World Journal of Gastrointestinal Surgery 2023; 15(9): 2032-2041 doi: 10.4240/wjgs.v15.i9.2032
Abstract(193) |
Core Tip(175) |
Full Article(HTML)(750)
|
Full Article with Cover (PDF)-1896K(43)
|
Full Article (Word)-476K(24)
|
Audio-365K(4)
|
Peer-Review Report-650K(27)
|
Answering Reviewers-143K(22)
|
Full Article (PDF)-1514K(64)
|
Full Article (XML)-87K(23)
|
Times Cited (0)
|
Total Visits (2236)
|
Open
|
| 21 |
Fatima De Palma, Valeria D’Argenio, Jonathan Pol, Guido Kroemer, Maria Maiuri, Francesco Salvatore. The Molecular Hallmarks of the Serrated Pathway in Colorectal Cancer. Cancers 2019; 11(7): 1017 doi: 10.3390/cancers11071017
|
| 22 |
Huizi Li, Changwen Jing, Jianzhong Wu, Jie Ni, Huanhuan Sha, Xiaoyue Xu, Yuanyuan Du, Rui Lou, Shuchen Dong, Jifeng Feng. Circulating tumor DNA detection: A potential tool for colorectal cancer management (Review). Oncology Letters 2018; doi: 10.3892/ol.2018.9794
|